UNSPSC 51284041: Rolitetracycline nitrate anhydrous

This classification denotes a tetracycline antibiotic with the molecular formula C27H33N3O8.HNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 496ESB4HTE, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-n-(1-pyrrolidinylmethyl)-, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, mononitrate (salt),, but more generally known as rolitetracycline nitrate anhydrous, which bears US NIH Compound Identifier 5360293.

UNSPSC 51284041 Rolitetracycline nitrate anhydrous is a Commodity code that in recent state and local procurement shows minimal alignment with its nominal pharmaceutical ingredient scope. The recent opportunities posted under this code actually solicit naloxone systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs — none of which center on rolitetracycline nitrate specifically. The mismatch between the code's name and the actual work being solicited suggests either broad misclassification by issuing bodies or that the code serves as a catch-all for pharmaceutical procurement rather than a precise commodity identifier. State and local issuers soliciting under this code include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance).

Geographic activity spans Florida, Texas, Minnesota, and Oregon, with recent solicitations concentrated in competitive procurement for pharmaceutical products, emergency medical supplies, and pharmacy benefit management capabilities. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies with an estimated contract value of $700,000.00, designated as sheltered for certified Small Local Business Enterprises with a 5% bid discount; the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) to explore direct-to-manufacturer prescription procurement models. The code shows activity but poor commodity-level precision — verify actual scope alignment before bidding.